FosB-null mice display impaired adult hippocampal neurogenesis and spontaneous epilepsy with depressive behavior

Neuropsychopharmacology

Volumn 38, Issue 5, 2013, Pages 895-906

  Yutsudo, Noriko ^a,b   Kamada, Takashi ^a   Kajitani, Kosuke ^a   Nomaru, Hiroko ^a   Katogi, Atsuhisa ^a   Ohnishi, Yoko H ^a,c   Ohnishi, Yoshinori N ^a,d   Takase, Kei Ichiro ^a   Sakumi, Kunihiko ^a   Shigeto, Hiroshi ^a   Nakabeppu, Yusaku ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adult neurogenesis; alternative splicing; epilepsy; immediate early gene; neural progenitor; proliferation

Indexed keywords

TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; EPILEPSY; GENE EXPRESSION; HIPPOCAMPUS; MALE; MICROARRAY ANALYSIS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BROMODEOXYURIDINE; CELL PROLIFERATION; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROARRAY ANALYSIS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NEUROGENESIS; NEUROPEPTIDES; PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 84875219064     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.260     Document Type: Article

References (50)

1. Abbosh C, Lawkowski A, Zaben M, Gray W (2011). GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors. J Neurochem 117: 425-436.
2. Anouar Y, Lee HW, Eiden LE (1999). Both inducible and constitutive activator protein-1-like transcription factors are used for transcriptional activation of the galanin gene by different first and second messenger pathways. Mol Pharmacol 56: 162-169.
3. Ben-Ari Y, Cossart R (2000). Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 23: 580-587.
4. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
5. Canu N, Possenti R, Rinaldi AM, Trani E, Levi A (1997). Molecular cloning and characterization of the human VGF promoter region. J Neurochem 68: 1390-1399.
6. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ (1997). Chronic Fos-related antigens: stable variants of DFosB induced in brain by chronic treatments. J Neurosci 17: 4933-4941.
7. Cote-Velez A, Perez-Martinez L, Diaz-Gallardo MY, Perez-Monter C, Carreon-Rodriguez A, Charli JL et al (2005). Dexamethasone represses cAMP rapid upregulation of TRH gene transcription: identification of a composite glucocorticoid response element and a cAMP response element in TRH promoter. J Mol Endocrinol 34: 177-197.
8. Danzer SC (2012). Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 233: 22-32.
9. Deng PY, Porter JE, Shin HS, Lei S (2006). Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J Physiol 577: 497-511.
10. Fahrner A, Kann G, Flubacher A, Heinrich C, Freiman TM, Zentner J et al (2007). Granule cell dispersion is not accompanied by enhanced neurogenesis in temporal lobe epilepsy patients. Exp Neurol 203: 320-332.
11. Flaherty L, Bolivar V (2007). Congenic and consomic strains. In: Jones BC, Mormede P (eds). Neurobehavioral Genetics. CRC Press, Taylor & Francis: Boca Raton, FL, pp 115-127.
12. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER (1992). Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258: 1903-1910.
13. Halmi P, Parkkila S, Honkaniemi J (2006). Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int 48: 24-30.
14. Hesdorffer DC, Caplan R, Berg AT (2012). Familial clustering of epilepsy and behavioral disorders: evidence for a shared genetic basis. Epilepsia 53: 301-307.
15. Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA et al (1998). Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci 18: 6952-6962.
16. Hyman SE, Comb M, Lin YS, Pearlberg J, Green MR, Goodman HM (1988). A common trans-acting factor is involved in transcriptional regulation of neurotransmitter genes by cyclic AMP. Mol Cell Biol 8: 4225-4233.
17. Inuzuka M, Hayakawa M, Ingi T (2005). Serinc, an activityregulated protein family, incorporates serine into membrane lipid synthesis. J Biol Chem 280: 35776-35783.
18. Kajitani K, Yamaguchi H, Dan Y, Furuichi M, Kang D, Nakabeppu Y (2006). MTH1, an oxidized purine nucleoside triphosphatase, suppresses the accumulation of oxidative damage of nucleic acids in the hippocampal microglia during kainate-induced excitotoxicity. J Neurosci 26: 1688-1698.
19. Kurushima H, Ohno M, Miura T, Nakamura TY, Horie H, Kadoya T et al (2005). Selective induction of DFosB in the brain after transient forebrain ischemia accompanied by an increased expression of galectin-1, and the implication of DFosB and galectin-1 in neuroprotection and neurogenesis. Cell Death Differ 12: 1078-1096.
20. Lason W, Przewlocka B, Van Luijtelaar G, Coenen A (1994). Proenkephalin and prodynorphin mRNA level in brain of rats with absence epilepsy. Neuropeptides 27: 343-347.
21. Lugert S, Basak O, Knuckles P, Haussler U, Fabel K, Gotz M et al (2010). Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging. Cell Stem Cell 6: 445-456.
22. Mandelzys A, Gruda MA, Bravo R, Morgan JI (1997). Absence of a persistently elevated 37 kDa fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J Neurosci 17: 5407-5415.
23. Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA et al (2000). Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20: 6276-6281.
24. McClung CA, Nestler EJ (2003). Regulation of gene expression and cocaine reward by CREB and DFosB. Nat Neurosci 6: 1208-1215.
25. Miyakawa T, Yagi T, Taniguchi M, Matsuura H, Tateishi K, Niki H (1995). Enhanced susceptibility of audiogenic seizures in Fyn-kinase deficient mice. Brain Res Mol Brain Res 28: 349-352.
26. Morris TA, Jafari N, DeLorenzo RJ (2000). Chronic DFosB expression and increased AP-1 transcription factor binding are associated with the long term plasticity changes in epilepsy. Brain Res Mol Brain Res 79: 138-149.
27. Murck H, Held K, Ziegenbein M, Kunzel H, Holsboer F, Steiger A (2004). Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29: 1205-1211.
28. Nakabeppu Y, Nathans D (1991). A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64: 751-759.
29. Nakabeppu Y, Oda S, Sekiguchi M (1993). Proliferative activation of quiescent Rat-1A cells by DFosB. Mol Cell Biol 13: 4157-4166.
30. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E et al (2003). Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23: 10841-10851.
31. Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB et al (2004). Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 9: 1007-1029.
32. Ohnishi YN, Ohnishi YH, Hokama M, Nomaru H, Yamazaki K, Tominaga Y et al (2011). FosB is essential for the enhancement of stress tolerance and antagonizes locomotor sensitization by DFosB. Biol Psychiatry 70: 487-495.
33. Ohnishi YN, Sakumi K, Yamazaki K, Ohnishi YH, Miura T, Tominaga Y et al (2008). Antagonistic regulation of cellmatrix adhesion by FosB and DFosB/D2DFosB encoded by alternatively spliced forms of fosB transcripts. Mol Biol Cell 19: 4717-4729.
34. Perucca P, Mula M (2012). Antiepileptic drug effects on mood and behavior: Molecular targets. Epilepsy Behav (in press), doi: 10.1016/j.yebeh.2012.09.018.
35. Pramparo T, Libiger O, Jain S, Li H, Youn YH, Hirotsune S et al (2011). Global developmental gene expression and pathway analysis of normal brain development and mouse models of human neuronal migration defects. PLoS Genet 7: e1001331.
36. Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I et al (2008). DFosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 28: 7344-7349.
37. Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R et al (2008). Doubly truncated FosB isoform (D2DFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J Bone Miner Res 23: 584-595.
38. Sattin A, Pekary AE, Lloyd RL (1994). TRH gene products are implicated in the antidepressant mechanisms of seizures. Ann NY Acad Sci 739: 135-153.
39. Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA (2011). Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476: 458-461.
40. Soriano FX, Leveille F, Papadia S, Higgins LG, Varley J, Baxter P et al (2008). Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione. J Neurochem 107: 533-543.
41. Surmacz B, Noisa P, Risner-Janiczek JR, Hui K, Ungless M, Cui W et al (2011). DLK1 promotes neurogenesis of human and mouse pluripotent stem cell-derived neural progenitors via modulating Notch and BMP signalling. Stem Cell Rev 8: 459-471.
42. Tahara K, Tsuchimoto D, Tominaga Y, Asoh S, Ohta S, Kitagawa M et al (2003). DFosB, but not FosB, induces delayed apoptosis independent of cell proliferation in the Rat1a embryo cell line. Cell Death Differ 10: 496-507.
43. Thakker-Varia S, Jean YY, Parikh P, Sizer CF, Jernstedt Ayer J, Parikh A et al (2010). The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J Neurosci 30: 9368-9380.
44. Thakker-Varia S, Krol JJ, Nettleton J, Bilimoria PM, Bangasser DA, Shors TJ et al (2007). The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 27: 12156-12167.
45. Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A (2001). Smad3/AP-1 interactions control transcriptional responses to TGF-b in a promoter-specific manner. Oncogene 20: 3332-3340.
46. Wang Y, Symes AJ (2010). Smad3 deficiency reduces neurogenesis in adult mice. J Mol Neurosci 41: 383-396.
47. Wang YY, Smith P, Murphy M, Cook M (2010). Global expression profiling in epileptogenesis: does it add to the confusion? Brain Pathol 20: 1-16.
48. Winum JY, Poulsen SA, Supuran CT (2009). Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 29: 419-435.
49. Yin D, Xie D, Sakajiri S, Miller CW, Zhu H, Popoviciu ML et al (2006). DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene 25: 1852-1861.
50. Zhang Y, Feng XH, Derynck R (1998). Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-b-induced transcription. Nature 394: 909-913.